Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra‐patient, prospective, comparison study in Italy

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 10, 2015-10 ,pp. : 1926-1932

John Wiley & Sons Inc

Access to resources Recommend Favorite

Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 9, 2015-09 ,pp. : 1718-1723

John Wiley & Sons Inc

Access to resources Recommend Favorite

Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase III study throughout Europe

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 12, 2015-12 ,pp. : 2342-2348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Simulated‐daylight photodynamic therapy with BF‐200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 4, 2015-04 ,pp. : 1146-1148

John Wiley & Sons Inc

Access to resources Recommend Favorite

A study of topical methyl‐aminolaevulinate red‐light photodynamic therapy in the treatment of actinic keratosis in Chinese patients: a Singaporean experience

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 5, 2015-07 ,pp. : 502-506

John Wiley & Sons Inc

Access to resources Recommend Favorite